Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
暂无分享,去创建一个
M. Perkins | F. Cobelens | D. Alland | M. T. Gler | M. Nicol | E. Gotuzzo | C. Boehme | P. Nabeta | Rasim Tahirli | R. Blakemore | J. Michael | W. Worodria | A. Whitelaw | H. Cox | T. Cáceres | H. Alexander | H. Albert | C. Gray | Laurence Huang | L. Raymond | R. Mehdiyev | K. Sagadevan
[1] R. Courcol,et al. Comparison of the Xpert MTB/RIF Test with an IS6110-TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens , 2011, Journal of Clinical Microbiology.
[2] M. Pandori,et al. Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens , 2011, Journal of Clinical Microbiology.
[3] F. Cobelens,et al. Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection , 2011, PloS one.
[4] F. Alcaide,et al. Rapid Detection of Mycobacterium tuberculosis Complex and Rifampin Resistance in Smear-Negative Clinical Samples by Use of an Integrated Real-Time PCR Method , 2010, Journal of Clinical Microbiology.
[5] Eduardo Gotuzzo,et al. Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.
[6] M. Perkins,et al. Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care Settings , 2010, Journal of Clinical Microbiology.
[7] P. Godfrey-Faussett,et al. Default during TB diagnosis: quantifying the problem , 2009, Tropical medicine & international health : TM & IH.
[8] Irene Ayakaka,et al. Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology , 2009, Journal of Clinical Microbiology.
[9] Oswaldo Jave,et al. Vigilancia nacional de la resistencia a medicamentos antituberculosos, Perú 2005-2006 , 2009 .
[10] K. Kam,et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance , 2009, The Lancet.
[11] M. Saleem,et al. Magnitude of initial default in pulmonary tuberculosis. , 2009, JPMA. The Journal of the Pakistan Medical Association.
[12] R. Tolhurst,et al. Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: A mixed methods study , 2008, BMC health services research.
[13] A. Ticona,et al. Tuberculosis en pacientes con VIH/SIDA , 2008 .
[14] E. Botha,et al. Initial default from tuberculosis treatment: how often does it happen and what are the reasons? , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] J. Hargrove,et al. The Effect of Diagnostic Delays on the Drop-Out Rate and the Total Delay to Diagnosis of Tuberculosis , 2008, PloS one.
[16] M. Perkins,et al. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. , 2007, The Journal of infectious diseases.
[17] K. Steingart,et al. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis , 2007, Expert review of anti-infective therapy.
[18] D. Enarson,et al. XDR tuberculosis: an indicator of public-health negligence , 2006, The Lancet.
[19] S. Rüsch-Gerdes,et al. Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[20] S. Tollman,et al. Undiagnosed pulmonary tuberculosis deaths in rural South Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[21] R. Duggal,et al. Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai , 2001, HIV medicine.
[22] A. Harries,et al. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa , 2001, AIDS.
[23] L. Lindquist,et al. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[24] M. Behr,et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli , 1999, The Lancet.
[25] Sonya S. Shin,et al. The dilemma of MDR-TB in the global era. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[26] H. Banda,et al. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[27] P. Glaziou,et al. High mortality rates among patients with tuberculosis in Bangui, Central African Republic , 1997, The Lancet.
[28] S. Oldham,et al. Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli , 1992, Annals of Internal Medicine.
[29] D. Snider,et al. Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[30] S. Theobald,et al. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.